Antitrust Antitrust

US Senate committee advances bill to improve drug-pricing transparency; Wicker questions FTC's 'catch-all hook'

A US Senate committee cleared a bill that would prevent unfair and deceptive practices related to pharmacy benefit-management services for prescription drugs in a 19-9 vote, but not before a Republican expressed concern about handing more power to the Federal Trade Commission.

In an executive session, the US Senate Commerce, Science and Transportation

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Discover MLex

Stay on top of global regulatory developments


Latest News